Comerica Bank Bei Gene, Ltd. Transaction History

Comerica Bank

$25 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$125.51 - $229.3 $78,443 - $143,312	-625 Reduced 24.05%	1,974 $0
Q3 2022 Oct 28, 2022	BUY	$131.8 - $202.24 $38,485 - $59,054	292 Added 12.66%	2,599 $405,000
Q2 2022 Aug 02, 2022	SELL	$121.11 - $216.05 $121 - $216	-1 Reduced 0.04%	2,307 $411,000
Q1 2022 Apr 27, 2022	BUY	$146.52 - $269.56 $5,421 - $9,973	37 Added 1.63%	2,308 $435,000
Q4 2021 Feb 18, 2022	BUY	$248.56 - $389.34 $7,208 - $11,290	29 Added 1.29%	2,271 $615,000
Q3 2021 Nov 22, 2021	SELL	$249.6 - $403.14 $925,267 - $1.49 Million	-3,707 Reduced 62.31%	2,242 $813,000
Q2 2021 Aug 26, 2021	BUY	$292.75 - $367.01 $27,225 - $34,131	93 Added 1.59%	5,949 $2.04 Million
Q1 2021 Apr 28, 2021	BUY	$260.64 - $382.12 $64,378 - $94,383	247 Added 4.4%	5,856 $2.04 Million
Q4 2020 Jan 28, 2021	SELL	$221.31 - $316.61 $44,040 - $63,005	-199 Reduced 3.43%	5,609 $1.45 Million
Q3 2020 Oct 30, 2020	BUY	$189.18 - $286.44 $134,506 - $203,658	711 Added 13.95%	5,808 $1.66 Million
Q2 2020 Jul 31, 2020	BUY	$123.9 - $195.41 $32,833 - $51,783	265 Added 5.48%	5,097 $960,000
Q1 2020 May 01, 2020	BUY	$121.84 - $173.19 $99,055 - $140,803	813 Added 20.23%	4,832 $594,000
Q4 2019 Feb 07, 2020	BUY	$115.78 - $208.34 $3,357 - $6,041	29 Added 0.73%	4,019 $666,000
Q3 2019 Oct 31, 2019	SELL	$120.61 - $148.29 $10,372 - $12,752	-86 Reduced 2.11%	3,990 $488,000
Q2 2019 Aug 02, 2019	SELL	$113.99 - $146.86 $32,943 - $42,442	-289 Reduced 6.62%	4,076 $0
Q1 2019 May 02, 2019	BUY	$122.82 - $151.83 $17,931 - $22,167	146 Added 3.46%	4,365 $0
Q4 2018 Feb 06, 2019	BUY	$107.01 - $175.15 $115,891 - $189,687	1,083 Added 34.53%	4,219 $522,000
Q3 2018 Nov 01, 2018	BUY	$152.62 - $189.66 $35,713 - $44,380	234 Added 8.06%	3,136 $366,000
Q2 2018 Aug 01, 2018	BUY	$152.5 - $216.77 $3,355 - $4,768	22 Added 0.76%	2,902 $476,000
Q1 2018 May 01, 2018	BUY	$97.41 - $177.22 $71,791 - $130,611	737 Added 34.39%	2,880 $495,000
Q4 2017 Feb 02, 2018	BUY	$79.6 - $114.73 $170,582 - $245,866	2,143	2,143 $246,000

Others Institutions Holding BGNE

# of Institutions

253

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$2.4 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.46 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$1.17 Billion
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$1.13 Billion
0.84% of portfolio
Baillie Gifford & CO

3.67M
Shares

$832 Million
0.54% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account